General Atlantic Sells Alignment Healthcare Shares
Analysis based on 10 articles · First reported Mar 02, 2026 · Last updated Mar 03, 2026
The market impact is likely neutral to slightly negative for Alignment Healthcare's stock, as a significant shareholder, General Atlantic, is selling a large block of shares, indicating a reduction in their stake. However, the company itself is not issuing new shares or receiving proceeds, so there is no direct dilution or capital infusion.
Alignment Healthcare, a Medicare Advantage company, announced the pricing of a public offering of 13,167,733 shares of its common stock by an affiliate of General Atlantic, L.P. The shares were priced at $19.46 per share, and the offering is expected to close on March 4, 2026. Alignment Healthcare will not receive any proceeds from this sale, as the shares are being sold by the existing shareholder, General Atlantic. JPMorgan Chase===J. P. Morgan is serving as the underwriter for this offering, which is being conducted pursuant to a shelf registration statement filed with the United States===United States Securities and Exchange Commission.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard